Identifying experiences of individuals with Type 2 diabetes during acceptance and adaptation of insulin therapy

Authors

  • Gulay Gulsen
  • Nermin Olgun

DOI:

https://doi.org/10.1080/20573316.2016.1242878

Keywords:

Diabetes, Insulin therapy, Adaption process, Qualitative

Abstract

This study was carried out in a qualitative manner in order to identify the emotions and life experience of the patients with Type 2 diabetes with regard to their acceptance of insulin therapy and their experience during adaptation process disease in the Endocrinology Clinic of Ondokuz Mayıs University between December 2014 through April 2015. The data was collected by employing interview form and in-depth interview. A voice recording was made in the interviews which lasted at least 5 minutes and written minutes of the data were issued within 24 hours following the interview. The content analysis was utilized in analyzing the qualitative and statistical data in connection with the demographic characteristics. In accordance with the results of the analysis, four groups and totally 14 themes are identified in which the obtained results are classified. For the purpose of ensuring the acceptance by the patients of the therapy and their adaptation to the process, it is suggested to mention about insulin therapy at the initial phase of the diabetes training, and provide assistance for the adaptation of insulin therapy through a sympathetic approach by making a planing based upon the individual needs.

Downloads

Download data is not yet available.

References

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33(1):11–61.

Bennet PH, Knowler WC. Definition, diagnosis and classification of diabetes mellitus and glucose homeostaisis. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, editors. Joslin diabetes mellitus. 14th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 331–9.

The Society of Endocrinology and Metabolism of Turkey (TEMD): Diabetes Mellitus Study and Training Groups. Guide for the Diagnosis, Treatment and Follow-up of Mellitus and Complications. 2015;7(15). http://www.temd.org.tr/files/7_DIYABET_Book%201_PRESS.pdf (accessed 13 July 15).

Lebovitz HE. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Cleve Clin J Med. 2002;69(10):809–20.

Monahan FD, Neighbors M, editors. Nursing care of patient with diabetes mellitus. Medical surgical nursing, foundations for clinical practice. 2nd ed. Philadelphia (PA): W. B. Saunders; 1998. p. 1223–63.

Nathan DM. Clinical practice. Initial management of glycaemia in type 2 diabetes mellitus. N Engl J Med. 2002;347(17):1342–49.

Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. prospective diabetes study (UKPDS 57). Diabetes Care. 2002;25(2):330–6.

Marrero DG. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Clin Cornerstone. 2007;8(2):33–43.

Polonsky WH, Fisher LF, Guzman S, Villa-Cabellero L, Edelman SV. Psychological insulin resistance in type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543–45.

United Kingdom Prospective Study (UKPDS). Group Intensive blood glucose control with sulphonylureas or compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lanset. 1998;352:837–53.

Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ. 2006;32(1):9S–18S.

Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ. 2009;35:1014–22.

Nakar S, Yitzhaki G, Rosenberg R, Vinker S. Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complicat. 2007;21(4):220–6.

Kousalya K, Vasantha J, Ponnudura R, Sumitkumar G, Ramalakshmı S, Saranya P, Chamundeeswarı D, Reddy CUM. Study on nonadherence and the effect of counselling in the pharmacological management of psychiatric patients. Int J Pharmaceut Bio Sci. 2012;3(1):102–9.

Tel H, Doğan S, Özkan B, Çoban S. Adaptation of patients having psychiatric disorder to therapy. Psychiat Nurs J. 2010;1:7–12.

Polit DF, Beck CT. Essentials of nursing research. 6th ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2006.

Tuckett A. Qualitative research sampling-the very real complexities. Nurse Res. 2004;12(1):47–61.

Pitney WA, Parker J. Qualitative research in physical activity and the health professions. Leeds: Human Kinetics Pub; 2009.

Erdoğan S, Nahçıvan N, Esin N, editors. 99 research, process, application and criticism in nursing. Istanbul: Nobel Bookstores; 2014. p. 131–65.

Çelik S, Pınar R. Insulin injection in individuals with diabetes and fear of finger lancing. J Psychiat Nurs. 2014;5(2):104–8.

Tan AM, Muthusamy L, Ng CC, Phoon KY, Ow JH, Tan NC. Singapore Med J. 2011;52(11):801–9.

Davis SN, Renda SM. Psychological insulin resistance: overcoming barriers to starting insulin therapy. Diabetes Educ. 2006;32(4):146S–152S.

Hassan A, Tohid H, Amin RM, Bidin MBL, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration, BMC family practice. Malezya. 2013;14:164.

Chen KW, Tseng HM, Huang YY, Chuang YJ. The barriers to initiating insulin therapy among people with type 2 diabetes, a qualitative study. J Diabetes Metab. 2012;3:194.

Ho EY, James J. Cultural barriers to initiating insulin therapy in Chinese people with type 2 diabetes living in Canada. Can J Diabetes. 2006;30:390–6.

Patel N, Stone MA, McDonough C, Davies MJ, Khuntiand K, Eborall H. Concerns and perceptions about necessity in relation to insulin therapy in an ethnically diverse UK population with type 2 diabetes: a qualitative study focusing mainly on people of South Asian origin. Diabet Med. 2015;32:635–44.

Çelik S. Turkish adaptation of self-injection in individuals with diabetes and fear of testing and Review of Psychometric Characteristics [Doctoral Thesis]. Istanbul; 2010. (Advisor: Prof. Dr. R Pınar).

Snoek FJ. Breaking the barriers to optimal glycemic control-what physicians need to know from patients’ perspectives. Int J Clin Pract. 2002;129:80–4.

Lacroix A, Assal JP. Therapeutic training of patients. Turkish Translation Editor Piyal B, Tabak RS. Ankara: Palme Publishing 2003.

Çakır F, İlnem C, Yener F. Compliance to follow-up and treatment after discharge among chronic psychotic patients. Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi. 2010;23(1):50–9.

Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9.

Arıkan Z, Kuruoğlu AÇ, Levent E, Köktürk O, Beler N, Oral N, Ekim NN, Köktürk O, Levent E. Perception of illness and personality features in tuberculosis patients. Kriz Dergisi. 2000;8(2):39–45.

Franciosi M, Pellegrini F, Berardis GD, Belfiglio M, Di Nardo B, Greenfield S, Kaplan HS, Sacco M, Tognoni G, Valentini M, Nicolicci A. Correlates of satisfaction for the relationship with their physician in type 2 diabetic patients. Diabetes Res Clin Pr. 2004;66:277–86.

Bonnet C, Gagnayre R, d'Ivernois JF. Difficulties of diabetic patients in learning about their illness. Patient Educ Couns. 2001;42:159–64.

Demirtaş A, Akbayrak N. Tip 2 determination of adaptation and acceptance criteria for patients with diabetes mellitus. Anatol J Clin Investig. 2009;3(1):10–18.

Türkcan DG, Çatalkaya D, Demir UD. Tip 2 review of self-care capacity of patients with diabetes mellitus. New Med J. 2009;26:210–3.

Larçin A, Polat G, Karadağ B. Nursing forum in diabetes, obesity, hypertension, ‘Review of effects of injection application methods and mistakes with patients with diabetes on metabolic control’. July–December 2010;2(2).

Downloads

Published

2016-09-01

How to Cite

Gulsen, G., & Olgun, N. (2016). Identifying experiences of individuals with Type 2 diabetes during acceptance and adaptation of insulin therapy. International Diabetes Nursing, 13(1), 21–28. https://doi.org/10.1080/20573316.2016.1242878

Issue

Section

Original Articles